Genomics

Company to provide Merck with genetic rat models

Published in Blood Weekly, April 29th, 2004

Ingenium Pharmaceuticals, AG, announced an agreement under which Ingenium shall seek to provide Merck & Co., Inc., (MRK) with novel genetic rat models with alterations in a gene specified by Merck.

No financial terms or further details of the agreement have been disclosed.

The models will be developed using Ingenium's INGENOtyping technology. As opposed to mouse "knockout" models, the development of genetic rat models remains a scientific hurdle despite years of intense research worldwide, due to the lack of rat embryonic stem cells. Nevertheless, the rat remains the model of choice for many therapeutic areas, including cardiovascular, behavioral,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2004-04-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry